β-Keto-N-methylphenethylamine (βk-NMPEA), also known as FTS-096, is a monoamine releasing agent of the phenethylamine family. It is the N-methyl analogue of phenacylamine (β-ketophenethylamine or α-desmethylcathinone) and the β-keto analogue of N-methylphenethylamine. The drug acts as a norepinephrine–dopamine releasing agent (NDRA), with values for induction of monoamine release of 148nM for norepinephrine, 1,860nM for dopamine, and >60,000nM for serotonin in rat brain synaptosomes. βk-NMPEA was first described in the scientific literature by 2019.
See also Phenylethanolamine (β-hydroxyphenethylamine) β-Methylphenethylamine Phenpromethamine (N,β-dimethylphenethylamine)
References
External links NM-AcP - Isomer Design